Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies

Microbiology

Volumn 142, Issue 3, 1996, Pages 707-715

  Little, Stephen F ^a   Novak, Jeanne M ^a,c   Lowe, John R ^a   Leppla, Stephen H ^a,b   Singh, Yogendra ^b,d   Klimpel, Kurt R ^b   Lidgerding, Burton C ^a,e   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^e SHEPHERD UNIVERSITY   (United States)

Author keywords

Bacillus anthracis; Epitope mapping; Protective antigen

Indexed keywords

ASPARAGINE; ASPARTIC ACID; BACTERIAL ANTIGEN; BACTERIAL TOXIN; CELL RECEPTOR; EPITOPE; IODINE 125; ISOLEUCINE; MONOCLONAL ANTIBODY; PHENYLALANINE; SERINE;

ANTIGEN RECOGNITION; ARTICLE; BACILLUS ANTHRACIS; LETHAL GENE; NONHUMAN; PRIORITY JOURNAL;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 0029958827     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-142-3-707     Document Type: Article

References (31)

1. Beall, F. A., Taylor, M. J. & Thorne, C. B. (1962). Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J Bacteriol 83, 1274-1280.
2. Bhatnagar, R., Singh, Y., Leppla, S. H. & Friedlander, A. M. (1989). Calcium is required for the expression of anthrax lethal toxin activity in the macrophage-like cell line J774A.1. Infect Immun 57, 2107-2114.
3. Brennand, D.M., Danson, M. J. & Hough, D.W. (1986). A comparison of ELISA screening methods for the production of monoclonal antibodies against soluble protein antigens. J Immunol Methods 93, 9-14.
4. Earley, E. M. & Osterling, M. C. (1985). Fusion of mouse-mouse cells to produce hybridoma secreting monoclonal antibody. J Tissue Cult Methods 9, 141-146.
5. Escuyer, V. & Collier, R. J. (1991). Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infect Immun 59, 3381-3386.
6. Ezzell, J. W., Ivins, B. E. & Leppla, S. H. (1984). Immunoelectrophoretic analysis, roxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect Immun 45, 761-767.
7. Fish, D. C., Mahlandt, B. G., Dobbs, J. P. & Lincoln, R. E. (1968). Purification and properties of in vitro-produced anthrax toxin components. J Bacteriol 95, 907-918.
8. Friedlander, A. M. (1986). Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem 261, 7123-7126.
9. Gordon, V. M., Leppla, S. H. & Hewlett, E. L. (1988). Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun 56, 1066-1069.
10. Green, L. M., Reade, J. L. & Ware, C. F. (1984). Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 70, 257-268.
11. Hollander, Z. & Katchalski-Katzir, E. (1986). Use of monoclonal antibodies to detect conformational alterations in lactate dehydrogenase isoenzyme 5 on heat denaturation and on adsorption to polystyrene plates. Mol Immunol 23, 927-933.
12. Kumpel, K. R., Arora, N. & Leppla, S. H. (1994). Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol Microbiol 13, 1093-1100.
13. Kochi, S. K., Schiavo, G., Mock, M. & Montecucco, C. (1994). Zinc content of the Bacillus anthracis lethal factor. FEMS Microbiol Lett 124, 343-348.
14. Leppla, S. H. (1982). Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells Proc Natl Acad Sci USA 79, 3162-3166.
15. Leppla, S. H (1988). Production and purification of anthrax toxin. Methods Enzymol 165, 103-116.
16. Leppla, S. H. (1991). The anthrax toxin complex. In Sourcebook of Bacterial Protein Toxins, pp. 277-302. Edited by J. E. Alouf & J. H. Freer. New York: Academic Press.
17. Leppla, S. H., Friedlander, A. M. & Cora, E. M. (1987). Proteolytic activation of anthrax toxin bound to cellular receptors. In Bacterial Protein Toxins, pp. 111-112. Edited by F. Fehrenbach, J. E. Alouf, P. Falmagne, W. Goebel, J. Jeljaszewicz, D. Jurgens &. R. Rappuoli. Stuttgart: Gustav Fischer.
18. Leppla, S. H., Friedlander, A. M., Singh, Y., Cora, E. M. & Bhatnagar, R. (1990). A model for anthrax toxic action at the cellular level. Salisbury Med Bull 68, 41-43.
19. Little, S. F. & Lowe, J. R. (1991). Location of receptor-binding region of protective antigen from Bacillus anthracis. Biochem Biophys Res Commun 180, 531-537.
20. Little, S. F., Leppla, S. H. & Cora, E. (1988). Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect Immun 56, 1807-1813.
21. Little, S. F., Leppla, S. H. & Friedlander, A. M. (1990). Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin. Infect Immun 58, 1606-1013.
22. Milne, J. C., Furlong, D. Hanna, P. C., Wall, J. S. & Collier, R. J. (1994). Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem 269, 20607-20612.
23. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
24. Novak, J. M., Stein, M.-P., Little, S. F., Leppla, S. H. & Friedlander, A. M. (1992). Functional characterization of protease-treated Bacillus anthracis protective antigen. J Biol Chem 267, 17186-17193.
25. Singh, Y., Chaudhary, V. K. & Leppla, S. H. (1989). A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in viro. J Biol Chem 264, 19103-19107.
26. Singh, Y., Klimpel, K. R., Quinn, C. P., Chaudhary, V. K. & Leppla, S. H. (1991). The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity. J Biol Chem 266, 15493-15497.
27. 315, in anthrax toxin protective antigen is required for translocation of lethal factor. J Biol Chem 269, 29039-29046.
28. Stanley, J. L. & Smith, H. (1961). Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol 26, 49-60.
29. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Prof Natl Acad Sci USA 76, 4350-4354.
30. Welkos, S. L., Lowe, J. R., Eden-McCutchan, F., Vodkin, M., Leppla, S. H. & Schmidt, J. J. (1988). Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene 69, 287-300.
31. Wu, X. C., Lee, W., Tran, L. & Wong, S. L. (1991). Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J Bacteriol 173, 4952-4958.